NCT07226999 2026-04-08
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Pfizer
Phase 2/3 Recruiting
Clinical Trials
11 trialsNCT07106528 2025-08-06
Organoid-guided vs Topotecan Therapy in Relapsed Extensive-Stage Small Cell Lung Cancer
Peking Union Medical College Hospital
Phase 2/3 Not yet recruiting
NCT01064466 2025-07-24
Drugs-SNPs
Medicine Invention Design, Inc
Phase 2/3 Active not recruiting
NCT03098030 2020-12-09
Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer
United Therapeutics
Phase 2/3 Completed
NCT04254471 2020-02-05
This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients
Haihe Biopharma Co., Ltd.
Phase 2/3 Unknown
NCT04192682 2020-01-06
Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer
Changzhou Cancer Hospital of Soochow University
Phase 2/3 Unknown
NCT03239171 2019-01-25
Bioinformation Therapy for Lung Cancer
Fuda Cancer Hospital, Guangzhou
Phase 2/3 Completed
NCT02772107 2016-05-17
Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer
Chinese PLA General Hospital
Phase 2/3 Unknown
NCT00930891 2016-03-10
CPC
Intergroupe Francophone de Cancerologie Thoracique
Phase 2/3 Completed
NCT00290953 2008-12-23
SESAME
Sanofi
Phase 2/3 Completed
NCT00168896 2006-02-14
A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
Charite University, Berlin, Germany
Phase 2/3 Unknown